Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342624 · ClinicalTrials.gov registry record · NA
Investigation of Cinnamon Spice on Glucose Tolerance in Subjects With Pre-diabetes
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04342624 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 20 participants.
The verdict
NCT04342624, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study aims to determine whether the effectiveness of cinnamon spice capsules vs. placebo capsules on glucose tolerance in prediabetic subjects who are overweight or obese.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Cinnamon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-04-14 |
| Est. Completion | 2023-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04342624
The ClinicalTrials.gov registry entry for NCT04342624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04342624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04342624 about?
NCT04342624 is a clinical study titled "Investigation of Cinnamon Spice on Glucose Tolerance in Subjects With Pre-diabetes". This study aims to determine whether the effectiveness of cinnamon spice capsules vs. placebo capsules on glucose tolerance in prediabetic subjects who are overweight or obese.
What is the current status of trial NCT04342624?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-04-14. Estimated completion is 2023-01-01.
What interventions are being tested in trial NCT04342624?
The interventions under investigation include: Placebo (OTHER), Cinnamon (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04342624?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.